Potential conflict of interest: Nothing to report.
Correspondence
Ribavirin pharmacokinetics and interleukin 28B plus cytochrome P450 27B1 single-nucleotide polymorphisms as predictors of response to pegylated interferon/ribavirin treatment in patients infected with hepatitis C virus genotype 1/4†
Article first published online: 30 NOV 2011
DOI: 10.1002/hep.24636
Copyright © 2011 American Association for the Study of Liver Diseases
Additional Information
How to Cite
D'Avolio, A., Ciancio, A., Siccardi, M., Baietto, L., Simiele, M., Cariti, G., Calcagno, A., Smedile, A., Cusato, J., Bonora, S., Rizzetto, M. and Di Perri, G. (2011), Ribavirin pharmacokinetics and interleukin 28B plus cytochrome P450 27B1 single-nucleotide polymorphisms as predictors of response to pegylated interferon/ribavirin treatment in patients infected with hepatitis C virus genotype 1/4. Hepatology, 54: 2279. doi: 10.1002/hep.24636
- †
Publication History
- Issue published online: 30 NOV 2011
- Article first published online: 30 NOV 2011
- Accepted manuscript online: 6 SEP 2011 10:08AM EST
- Manuscript Accepted: 31 JUL 2011
- Manuscript Received: 27 JUL 2011
No abstract is available for this article.

1527-3350/asset/olbannerleft.gif?v=1&s=4b2409f9534ed500d3c8da1940a23842e2b9932d)
1527-3350/asset/olbannerright.gif?v=1&s=141b9a8485298533c3e2016e937b0404f7d933e1)
1527-3350/asset/cover.gif?v=1&s=3cd983af6575c8dbfd6b47a63ffa95415ace15f8)